Pharmacology of the 'gasotransmitters' NO, CO and H2S: Translational opportunities

British Journal of Pharmacology

Volumn 172, Issue 6, 2015, Pages 1395-1396

  Papapetropoulos, Andreas ^a   Foresti, Roberta ^b,c   Ferdinandy, Péter ^d,e  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c INSERM U955   (France)

^d PHARMAHUNGARY GROUP   (Hungary)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CYCLIC GMP; GASOTRANSMITTER; HEME; HYDROGEN SULFIDE; ION CHANNEL; IRON; MYELOPEROXIDASE; NITRIC OXIDE;

ACUTE DISEASE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; BLOOD PRESSURE REGULATION; CENTRAL NERVOUS SYSTEM DISEASE; COMORBIDITY; DIGESTIVE SYSTEM INFLAMMATION; DISEASE COURSE; EDITORIAL; ENZYME INHIBITION; HEART PROTECTION; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE INFERTILITY; METABOLIC DISORDER; MITOCHONDRION; MOLECULAR INTERACTION; NITROSATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN INTERACTION; SEXUAL DYSFUNCTION; SIGNAL TRANSDUCTION; METABOLISM; PHYSIOLOGY;

CARBON MONOXIDE; GASOTRANSMITTERS; HUMANS; HYDROGEN SULFIDE; NITRIC OXIDE; SIGNAL TRANSDUCTION;

EID: 84923777765     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13005     Document Type: Editorial

References (19)

1. Ahmed A, Ramma W, (2015). Unraveling the theories of preeclampsia: Are the protective pathways the new paradigm? Br J Pharmacol 172: 1574-1586.
2. 2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. Br J Pharmacol 172: 1587-1606.
3. Babu D, Motterlini R, Lefebvre RA, (2015). CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation. Br J Pharmacol 172: 1557-1573.
4. Bos EM, van Goor H, Joles JA, Whiteman M, Leuvenink HGD, (2015). Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. Br J Pharmacol 172: 1479-1493.
5. 2S biosynthesis induced by testosterone. Br J Pharmacol 172: 1505-1515.
6. Buzadzic B, Vucetic M, Jankovic A, Stancic A, Korac A, Korac B, et al. (2015). New insights into male (in)fertility: the importance of NO. Br J Pharmacol 172: 1455-1467
7. Csonka C, Páli T, Bencsik P, Görbe A, Ferdinandy P, Csont T,. (2015). Measurement of NO in biological samples. Br J Pharmacol 172: 1620-1632
8. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R,. (2014). Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning. Pharmacol Rev 66: 1142-1174.
9. Pálinkás Z, Furtmüller PG, Nagy A, Jakopitsch C, Pirker KF, Magierowski M, et al. (2015). Interactions of hydrogen sulfide with myeloperoxidase. Br J Pharmacol 172: 1516-1532.
10. Papapetropoulos A, Hobbs AJ, Topouzis S, (2015). Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS. Br J Pharmacol 172: 1397-1414.
11. Papapetropoulos A, Whiteman M, Cirino G, (2015). Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners. Br J Pharmacol 172: 1633-1637.
12. Pechánová O, Varga ZV, Cebová M, Giricz Z, Pacher P, Ferdinandy P, (2015). Cardiac NO signalling in the metabolic syndrome. Br J Pharmacol 172: 1415-1433.
13. Peers C, Boyle JP, Scragg JL, Dallas ML, Al-Owais MM, Hettiarachichi NT, et al. (2015). Diverse mechanisms underlying the regulation of ion channels by carbon monoxide. Br J Pharmacol 172: 1546-1556.
14. Queiroga CS, Vercelli A, Vieira HL, (2015). Carbon monoxide and the CNS: challenges and achievements. Br J Pharmacol 172: 1533-1545.
15. Santos AI, Martínez-Ruiz A, Araújo IM, (2015). S-nitrosation and neuronal plasticity. Br J Pharmacol 172: 1468-1478.
16. Schatzschneider U, (2015). Novel lead structures and activation mechanisms for CO-releasing molecules (CORMs). Br J Pharmacol 172: 1638-1650.
17. Snijder PM, Frenay AS, de Boer RA, Pasch A, Hillebrands J, Leuvenink HGD, et al. (2015). Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats. Br J Pharmacol 172: 1494-1504.
18. Wesseling S, Fledderus JO, Verhaar MC, Joles JA, (2015). Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal. Br J Pharmacol 172: 1607-1619.
19. Yetik-Anacak G, Sorrentino R, Linder AE, Murat N, (2015). Gas what: NO is not the only answer to sexual function. Br J Pharmacol 172: 1434-1454.